World Hepatitis Day 2026

Uniting for a Hepatitis-Free Future with Sejoy Urine Analysis Test Strips
On July 28, 2026, the world marks World Hepatitis Day, a global call to action to raise awareness about viral hepatitis—a silent public health crisis that affects over 325 million people worldwide. This year’s theme, “One Life, One Liver,” emphasizes the urgency of early detection, access to treatment, and eliminating hepatitis as a public health threat by 2030. Amidst this global effort, innovative tools like Sejoy urine analysis test strips are playing a pivotal role in making hepatitis screening more accessible, affordable, and efficient, particularly in low-resource regions where diagnostic barriers remain a major challenge.

Viral hepatitis, including hepatitis B and C, often progresses without symptoms for years, leading to chronic liver disease, cirrhosis, and liver cancer. According to the World Health Organization (WHO), over 1.3 million people die each year from hepatitis-related complications, yet 90% of those living with the virus are unaware of their infection. This gap in diagnosis is driven by systemic barriers: high costs of testing, limited access to healthcare facilities, and the stigma associated with liver diseases. For marginalized communities in sub-Saharan Africa, Southeast Asia, and Latin America, these obstacles are often insurmountable. However, Sejoy urine analysis test strips are changing this narrative by providing a non-invasive, cost-effective solution that can be used in primary care clinics, community health centers, and even remote settings without specialized training.

What sets Sejoy urine analysis test strips apart is their simplicity and accuracy. Unlike traditional blood tests, which require laboratory processing and trained personnel, these strips allow users to detect liver enzyme abnormalities—an early indicator of hepatitis—in minutes using just a urine sample. The strips measure levels of bilirubin and urobilinogen, two biomarkers that rise significantly in the presence of liver damage. For healthcare workers in rural areas, this means they can screen patients during routine visits, enabling immediate referrals for confirmatory testing and treatment. In countries like India and Nigeria, where hepatitis prevalence rates exceed 5%, this technology has the potential to reach millions who would otherwise go undiagnosed. Dr. Amara Kone, a WHO epidemiologist working in West Africa, notes: “Sejoy urine analysis test strips are a game-changer. They turn every community health worker into a frontline detective, empowering them to catch hepatitis early and save lives.”

World Hepatitis Day 2026 is a reminder that eliminating hepatitis requires collaboration across governments, healthcare providers, and the private sector. Sejoy, a global leader in medical diagnostics, has long been committed to this mission, investing in research and development to create tools that address unmet public health needs. The company’s urine analysis test strips are part of a broader portfolio of point-of-care diagnostic solutions designed to bridge the gap between innovation and accessibility. By partnering with NGOs, governments, and local healthcare organizations, Sejoy is ensuring that these tools reach the communities that need them most.

As we reflect on World Hepatitis Day, it is clear that the fight against hepatitis is not just about medical breakthroughs—it is about ensuring that those breakthroughs reach everyone, everywhere. Sejoy urine analysis test strips embody this vision, proving that simple, affordable technology can have a profound impact on global health. They remind us that no one should be left behind in the quest for a hepatitis-free world. This World Hepatitis Day, let us unite to raise awareness, break down barriers, and support innovations that turn the tide against this silent epidemic. Together, with tools like Sejoy’s urine analysis test strips, we can make the WHO’s 2030 elimination goal a reality—one test, one life, one liver at a time.